KAVA KAVA

KAVA KAVA



Botanical name: Piper methysticum


Family name: Piperacaea


Synonyms: Kava, kava pepper, kawa, awa


Part used: Peeled dry rhizome






TRADITIONAL AND HISTORICAL USES


Kava kava use is deeply rooted in the ceremonial and daily recreational traditions of South Pacific Islanders, particularly Polynesia, Melanesia, and Micronesia, together known as Oceania, with heavy use found in Fiji, Samoa, and Tonga. Use spread to Australia via missionaries from the South Pacific, and it was traditionally also very popular in Hawaii, although a death penalty instituted for its use there eventually led to decreased consumption among Hawaiians. Legends abound regarding “the kava,” which is believed to be the child of their god of good seasons and rain, and patron deity of farmers. Kava kava use is accompanied by specific rituals, including the use of a special kava bowl (tanoa), strainer (tau’anga), and cup (ipu), also believed to be gifts from the gods accompanying the herb. Kava kava was traditionally taken as a beverage prepared as a cold infusion. The root is chewed, grated, powdered, or macerated and placed inside the kava bowl to which cold water is then added. This mash is steeped and strained repeatedly, then poured into cups for drinking. Kava kava is used in formal ceremonies such as political events, marriages, and births; at important and official meetings such as contract signings; and also more casually and informally



on social occasions; and even recreationally, for example, at the start of the day by old men, or at the end of a long work day. Reports say that is has also been used to cure illness, help soothe arguments, and even as part of ceremonies at which disputes are resolved or differences between enemies are reconciled. One might say it is considered the beverage of hospitality in the South Pacific.


Traditional medicinal indications for kava kava use include use as an intoxicant, a nervine, and neuromuscular restorative (e.g., calming the nerves, inducing relaxation and sleep, relieving headache, counteracting fatigue or weakness, and restoring muscle strength in asthma and rheumatism). It was used as a diaphoretic in the treatment of chills and head colds, and for asthma. Another important medicinal use was as a diuretic, particularly for difficulty urinating and the treatment of chronic cystitis, syphilis, and gonorrhea.


It was first described and named Piper methysticum, meaning “intoxicating pepper” in 1786, and was not highly used as a medicinal plant in Western botanical medicine. It was recognized by the Eclectics in the late nineteenth century as a local anesthetic, CNS depressant, and cardiac stimulant, and as a treatment for gonorrhea. In the early twentieth century the Eclectics cited its use for neuralgic conditions of the eyes, ears, and teeth, for edema, and for gastric atony and postsurgical anorexia. The herb was listed in the 20th to 24th editions of The United States Dispensatory of the United States of America (1918–1947) and the fluid extract had official status in the 4th and 5th editions of the National Formulary (1888–1926).




IN VITRO, ANIMAL, AND CLINICAL DATA


The anxiolytic effects of kava kava have been the focus of most clinical trials, and results have generally supported the benefits of kava kava and kavalactones in the treatment of anxiety and anxiety disorders.


A Cochrane systematic review of kava kava monopreparations for the treatment of anxiety identified 12 double-blind placebo-controlled RCTs (n = 700) that met all inclusion criteria, all but one of which used a product standardized to 70% kavalactones, and produced by the same manufacturer. Data from seven trials (n = 380) assessed a common outcome measure—the total score on the HAM-A—and 74% of these patients (n = 282) were diagnosed according to the criteria of the American Psychiatric Association DSM-III-R and DSM-IV. All trials used the HAM-A total score at baseline as an inclusion criterion, and four trials included patients if the total score was 19 or above. One trial included only women with anxiety resulting from climacteric syndrome. The results of the meta-analysis suggest a significant reduction of the HAM-A total score in patients receiving kava kava extract compared with placebo. The results of the five studies that were not submitted to meta-analysis largely support these findings. Five other systematic reviews support these findings. Numerous pharmacologic studies have been conducted with kava kava extracts and isolated kavalactones. The most important findings suggest that kava kava and its preparations possess anxiolytic, anticonvulsive, neuroprotective, sedative, and local anesthetic effects. Kava kava has been demonstrated in animal and human clinical trials to improve sleep parameters. In a human clinical trial (n = 12) kava kava extract was shown to reduce sleep latency, improve deep sleep, and subjects reported a subjective sense of increased quality of sleep, with improved cognitive function compared with oxazepam, which led to impaired function. Additional human clinical trials have demonstrated improvements in cognitive function and performance with kava kava intake. Kava kava and isolated constituents have demonstrated topical analgesic effects in several animal studies. In one study, a 0.5% solution of kavain had an anesthetic effect equivalent to that of cocaine. The effect of a 3% solution of either compound had a comparable effect on the endurance of total anesthesia, extending it from 5.3 minutes for kavain and from 6.5 minutes for cocaine to approximately 31 minutes for both substances. Animal studies have demonstrated dose dependent muscle relaxant capabilities as well as anticonvulsant effects.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 24, 2016 | Posted by in GYNECOLOGY | Comments Off on KAVA KAVA

Full access? Get Clinical Tree

Get Clinical Tree app for offline access